[Study for the treatment of nonmuscle invasive bladder cancer : A phase III efficacy trial for intravesical instillation of mistletoe extract in superficial bladder cancer (TIM) - AB 40/11 of the AUO].
MeckEvidence, Seestr. 11, 17252, Schwarz, Deutschland. auo.presse@MeckEvidence.de.
H
H
Rexer
D000283:Administration, Intravesical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D014784:Mistletoe / Q000737:chemistry*; D009130:Muscle, Smooth / Q000473:pathology; D009361:Neoplasm Invasiveness; D010936:Plant Extracts / Q000008:administration & dosage*; D012107:Research Design; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D055815:Young Adult
D000970:Antineoplastic Agents; D010936:Plant Extracts